Pistoia Alliance predicts a focus on fight against antimicrobial resistance & a surge in quantum computing research for 2022

(BioITWorld) The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has toutlined predictions for the life sciences industry in 2022. The predictions come from three experts recently appointed by the Alliance to drive collaboration efforts across its three key themes. Their insights span the urgent fights against antimicrobial resistance, the potential of quantum computing and commercial space travel, and autonomous laboratories. Throughout 2021, digital transformation has continued to accelerate and the pharmaceutical industry has further embraced collaboration, both of which will underpin success in emerging areas in the next 12 months.
Imran Haq, Emerging Science and Technology theme lead, Pistoia Alliance: “Driven by macro geopolitical trends and Big Tech, emerging technologies are being developed increasingly rapidly. Reflecting this, deal making in the quantum space will continue to grow a pace in 2022. As the buzz around the sector increases, will this be the year we finally start to see translation of this buzz into early versions of applications and use cases in the pharma industry? A likely quantum use case could be to improve supply chain efficiency. Big promises have been made during COP26, and large organizations, including pharma companies, must have net zero strategies. This is also an area we would like to explore with the Pistoia Alliance’s Quantum Computing Community of Interest.”